Replies to post #179093 on Amarin Corp Plc (AMRN)

[rfj1862]

I mean there's no question that REDUCE-IT is mentioned for the first time in the guidelines but that is an entirely different thing from being added to the algorithm for the appropriate REDUCE IT patient population.

I have been involved in numerous guideline writing committees. It is not at all unusual for the drug to be mentioned in the discussion section as a first step toward being included formally in the algorithms. Ultimately it will move into a formal recommendation if the data continue to support.

I guess on the plus side, they mention REDUCE IT without any mineral oil caveats!

given where the information came from, I really didn't think twice to question him. It was very late in the evening, and in his calm and collected usual self, he just came out with this information, which was just another item among others. He said, quote: "Are you familiar with AACE/ADA?" "Well, they just added Vascepa to their guidelines". "That's great because lazy doctors love guideless to follow step by step". I had to jump on the board to share this obviously but didn't expect pushback. But I did have enough time to catch him before we parted to ask what his source was? He replied, "The reps told me at the office yesterday", something to the effect that Amarin released this update to all the reps company-wide.

[Biobillionair]

Great, let’s us know either way, it might not be an Amarin rep source.... again thank your bro and thank you for sharing your DD.
BB